Qiana L. Matthews Department of Medicine University of Alabama at Birmingham Biography Publications Institution JoVE Articles Qiana L. Matthews has not added a biography. If you are Qiana L. Matthews and would like to personalize this page please email our Author Liaison for assistance. Publications Neural Stem Cell-derived Exosomes Mediate Viral Entry International Journal of Nanomedicine. 2014 | Pubmed ID: 25364247 Monitoring of Biodistribution and Persistence of Conditionally Replicative Adenovirus in a Murine Model of Ovarian Cancer Using Capsid-incorporated MCherry and Expression of Human Somatostatin Receptor Subtype 2 Gene Molecular Imaging. 2014 | Pubmed ID: 25249483 Immunization with Hexon Modified Adenoviral Vectors Integrated with Gp83 Epitope Provides Protection Against Trypanosoma Cruzi Infection PLoS Neglected Tropical Diseases. Aug, 2014 | Pubmed ID: 25144771 A Recombinant Adenovirus-based Vector Elicits a Specific Humoral Immune Response Against the V3 Loop of HIV-1 Gp120 in Mice Through the "Antigen Capsid-Incorporation" Strategy Virology Journal. 2014 | Pubmed ID: 24935650 Using Multivalent Adenoviral Vectors for HIV Vaccination PloS One. 2013 | Pubmed ID: 23555957 Therapeutic Efficacy of an Oncolytic Adenovirus Containing RGD Ligand in Minor Capsid Protein IX and Fiber, Δ24DoubleRGD, in an Ovarian Cancer Model Journal of Molecular Biochemistry. Feb, 2012 | Pubmed ID: 23998042 Gene Transfer of Active Akt1 by an Infectivity-enhanced Adenovirus Impacts β-cell Survival and Proliferation Differentially in Vitro and in Vivo Islets. Nov-Dec, 2012 | Pubmed ID: 23183538 Transforming Growth Factor β Suppresses Glutamate-cysteine Ligase Gene Expression and Induces Oxidative Stress in a Lung Fibrosis Model Free Radical Biology & Medicine. Aug, 2012 | Pubmed ID: 22634145 Capsid-incorporation of Antigens into Adenovirus Capsid Proteins for a Vaccine Approach Molecular Pharmaceutics. Feb, 2011 | Pubmed ID: 21047139 Role of RGD-containing Ligands in Targeting Cellular Integrins: Applications for Ovarian Cancer Virotherapy (Review) Experimental and Therapeutic Medicine. Mar, 2010 | Pubmed ID: 21494315 Current Progress in the Development of a Prophylactic Vaccine for HIV-1 Drug Design, Development and Therapy. 2010 | Pubmed ID: 21267356 HIV Antigen Incorporation Within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach PloS One. 2010 | Pubmed ID: 20676400 Evaluation of Adenovirus Capsid Labeling Versus Transgene Expression Virology Journal. 2010 | Pubmed ID: 20102632 Derivation of a Triple Mosaic Adenovirus for Cancer Gene Therapy PloS One. 2009 | Pubmed ID: 20046872 Strategies to Overcome Host Immunity to Adenovirus Vectors in Vaccine Development Expert Review of Vaccines. Jun, 2009 | Pubmed ID: 19485756 Optimization of Capsid-incorporated Antigens for a Novel Adenovirus Vaccine Approach Virology Journal. 2008 | Pubmed ID: 18718011 Derivation of a Triple Mosaic Adenovirus Based on Modification of the Minor Capsid Protein IX Virology. Aug, 2008 | Pubmed ID: 18570971 Gene Therapy: Human Germline Genetic Modifications--assessing the Scientific, Socioethical, and Religious Issues Southern Medical Journal. Jan, 2007 | Pubmed ID: 17269544 Combining High Selectivity of Replication Via CXCR4 Promoter with Fiber Chimerism for Effective Adenoviral Oncolysis in Breast Cancer International Journal of Cancer. Journal International Du Cancer. Feb, 2007 | Pubmed ID: 17131341 Genetic Incorporation of a Herpes Simplex Virus Type 1 Thymidine Kinase and Firefly Luciferase Fusion into the Adenovirus Protein IX for Functional Display on the Virion Molecular Imaging. Oct-Dec, 2006 | Pubmed ID: 17150163 Employment of Microarray Analysis to Characterize Biologic Differences Associated with Tropism-modified Adenoviral Vectors: Utilization of Non-native Cellular Entry Pathways Cancer Gene Therapy. Feb, 2005 | Pubmed ID: 15375380 Enhanced Gene Transfer to Mouse Dendritic Cells Using Adenoviral Vectors Coated with a Novel Adapter Molecule Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2004 | Pubmed ID: 15120332 Utilisant la stratégie capside-Incorporation Antigen pour le développement d'approches adénovirus sérotype 5 Vectored vaccins Linlin Gu1, Anitra L. Farrow1, Alexandre Krendelchtchikov1, Qiana L. Matthews1,2 1Department of Medicine, University of Alabama at Birmingham, 2Center for AIDS Research, University of Alabama at Birmingham JoVE 52655 Immunologie et Infection
Utilisant la stratégie capside-Incorporation Antigen pour le développement d'approches adénovirus sérotype 5 Vectored vaccins Linlin Gu1, Anitra L. Farrow1, Alexandre Krendelchtchikov1, Qiana L. Matthews1,2 1Department of Medicine, University of Alabama at Birmingham, 2Center for AIDS Research, University of Alabama at Birmingham JoVE 52655 Immunologie et Infection